Differences in Ca 15-3 and Homocysteine Levels in Patients with Benign Tumor and Breast Cancer
More than 25% of women have complaints related to breast lumps during their lifetime and approximately 12% have breast cancer. Cancer antigen 15-3 and homocysteine can be used as biomarkers in breast cancer. Breast cancer produces pro-inflammatory cytokines that can lead to increased CA 15-3 levels...
Saved in:
| Main Authors: | Mathink Toonov ANUGERAWATI, Indranila Kustarini SAMSURIA, I Edward Kurnia Setiawan LIMIJADI, Dwi RETNONINGRUM, Banundari RACHMAWATI |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bucharest College of Physicians
2024-03-01
|
| Series: | Modern Medicine |
| Subjects: | |
| Online Access: | https://medicinamoderna.ro/wp-content/uploads/2024/03/Differences-in-Ca-15-3-and-Homocysteine-Levels-in-Patients-with-Benign-Tumor-and-Breast-Cancer.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Homocysteine and Folic Acid Levels as Risk Factors of Chronic Kidney Disease
by: Esa Loyallita LESTARI, et al.
Published: (2024-03-01) -
Risk factors for breast cancer in patients with benign breast diseases: a 10-year observational study
by: R. M. Shabaev, et al.
Published: (2024-05-01) -
A modern view at the differential ultrasound diagnosis of hyperechoic benign tumors of the breast
by: T. Yu. Danzanova, et al.
Published: (2022-05-01) -
Dynamics of the incidence of benign breast disease at the regional level
by: O. Yu. Sevostyanova, et al.
Published: (2023-08-01) -
Memenin Benign Lezyonlarından Fibromatozis
by: Bartu Badak, et al.
Published: (2021-09-01)